483
Lazurite Inc.FDA 483 - Lazurite Inc. - February 07, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Lazurite Inc., a medical device manufacturer in Cleveland, OH, revealed significant deficiencies across its quality system. The firm was cited for inadequate risk analysis, poorly documented design input requirements, and insufficient design validation procedures. Additionally, issues were found with supplier control and procedures for handling nonconforming products, indicating a broad need for quality system improvements.
Open in Dashboard
ID · e511c321-3f41-4770-bd43-1b72b9dfa9c5